Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials - D’Angelo, S P; Mahoney, M R; Van Tine, B A (Lancet Oncol, 2018)
et al.